HD-PLC-ALLIANCE
8.3.2021 07:02:11 CET | Business Wire | Press release
Last year, HD-PLC Alliance *1 , Fukuoka, Japan (Alliance) launched the “Global Strategy Preparatory Office”, a new ad-hoc working group, to support the advancement of IoT migration which is leading to a dramatic growth of the needs for high-speed PLC in various systems such as smart-meter, factory-automation (FA), building-automation (BA), solar power generation, smart-streetlight, smarter-city, smarter-home, etc.
The Alliance announces today several initiatives as part of the development of its global activities.
First, the Alliance will hold an HD-PLC *2 global web seminar (webinar) jointly with IEEE SA*3 on coming Thursday, 18th March to showcase its ecosystem footprint.
-
Event title: [IEEE SA And HD-PLC Alliance Webinar March 2021]
Home Networking, Industrial and Building Automation through HD-PLC (High Speed Powerline Communication)
- Official website: https://hd-plc.org/news/ , https://standards.ieee.org/events/index.html
- Topics covered/Agenda: HD-PLC technology and Standards, Building Automation, Industrial Case Studies, In-home systems, Internet of Things (IoT), HD-PLC licensing program
- Presenter: IEEE 1901 Working Group Chair, Panasonic, MegaChips, Alliance Chair and Manager
The official website has been completely renewed in February this year and the Alliance has increased its presence on the SNS site such as Facebook, LinkedIn to disseminate more information globally.
The Alliance will actively contribute to the activities of global standardization in cooperation with IEEE despite of COVID-19 disaster these days.
Since its establishment in 2007, the Alliance has carried out global activities in Europe, U.S.A, Asia to expand and spread HD-PLC and to ensure interoperability. As a result, the global IEEE Standard 1901*4 was approved in 2010, adopting HD-PLC as core technology. "The IEEE 1901 standard is the FIRST standard that converted scattered initiatives into a profitable industry offering assurance of interoperability to users” said Jean-Philippe Faure, IEEE 1901 Working Group Chair.
In 2012 the HD-PLC technology was adopted in the Chinese national standard GB/T 29265.305-2012 *5 . Additionally, U.S. standard ANSI/CTA 709.8 LON HD-PLC*6 , based on IEEE std 1901, has been approved in 2020. This shows that HD-PLC is broadly recognized as one of most popular global High-speed Power Line Communication standard.
The Alliance has continuously contributed and will continue to contribute to the evolution of the IEEE 1901 standard. "The continuous development of amendments within the IEEE 1901 Working Group consolidates the technology, inspires new uses in new sectors - LON standard - and expands the PLC market to new generations of products.” continued Jean-Philippe Faure. The last achievement was the publication of IEEE Std 1901-2020.
Note:
- The unincorporated association founded by Panasonic Corporation in 2017, which aims to expand and increase the use of HD-PLC and ensure interoperability between equipment with built-in HD-PLC.
- An abbreviation for “High Definition Power Line Communication” originally. HD-PLC™ or HD-PLC™ mark is a registered trademark or trademark of Panasonic Corporation in Japan and in other countries.
- The IEEE (Institute of Electrical and Electronics Engineers, U.S.A) Standards Association.
-
The global standard on high-speed Power Line Communication that adopted HD-PLC as core technology in 2010. The latest revision, IEEE 1901 std-2020, has been published in January 2021.
https://standards.ieee.org/standard/1901-2020.html - IGRS (a communication industry organization in China), the Alliance, Panasonic, etc. worked for this standardization together. It was approved in 2012.
- American National Standards Institute (ANSI) approved as American National Standard (ANS).
View source version on businesswire.com: https://www.businesswire.com/news/home/20210307005013/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Biocytogen Grants Taisho Pharmaceutical a License to its RenNano® Fully Human Heavy Chain-Only Antibody Discovery Platform30.3.2026 13:00:00 CEST | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that it has entered into a platform license agreement with Taisho Pharmaceutical Co., Ltd. (“Taisho”), granting Taisho the right to access and use Biocytogen’s proprietary RenNano® fully human heavy chain-only antibody (HCAbs) discovery platform for its internal research and development programs. Under the terms of the agreement, Taisho will leverage RenNano® mice to enable the generation and screening of fully human HCAbs in vivo and to support downstream research associated with antibody discovery. Financial terms of the agreement have not been disclosed. “We are very pleased to enter into this collaboration with Taisho,” said Dr. Yuelei Shen, President and CEO of Biocytogen. “RenNano® is a robust and powerful fully human VHH discovery platform that pro
Meiji Seika Pharma Invests in Centivax to Develop Next Generation Universal Vaccine Platform30.3.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Head Office: Chuo-ku, Tokyo, President and Representative Director: Toshiaki Nagasato) today announced a strategic investment in Centivax, Inc. (Head Office: South San Francisco, CA, USA), a biotechnology company developing next-generation vaccines and therapies for universal protection against highly diverse targets. Centivax’s lead program includes a universal seasonal influenza vaccine (Centi-Flu 01) currently in a Phase 1 clinical study. Unlike conventional seasonal flu vaccines, which must be manufactured annually based on recommended candidate vaccine viruses, Centivax’s platform focuses both antibody and cellular immune responses on conserved regions of the influenza virus that cannot mutate and are shared across strains and distant subtypes. This approach aims to generate broad, consistent, and durable immunity against both seasonal and pandemic influenza. Meiji’s strategic investment aims to accelerate the advancement of Centi-Flu 01 and further a
Samsung Biologics Strike: Labor Union Warns of CDMO Supply Chain Risks Following Overwhelming Vote30.3.2026 11:52:00 CEST | Press release
Union members overwhelmingly approve strike action with 95.52% voting in favor on a 95.38% turnout, clearing the final legal hurdle after mediation ceased.Union emphasizes this is a fight against structural corporate governance issues, citing unresolved allegations concerning unfair labor practices and ESG compliance risks.Management adhered to a group-level wage guideline rather than bargaining on the basis of Samsung Biologics' own performance, exposing a lack of independent bargaining authority. The Samsung Biologics Labor Union (President: Jaesung Park), representing approximately 75% of the company's total employees, announced today that its members have overwhelmingly voted in favor of a strike, with 95.52% voting in favor on a 95.38% turnout during a voting period from March 24 to March 29. Following the Incheon Regional Labor Relations Commission's decision to cease mediation, the union has now secured the legal mandate to strike. The union stressed that this strike is not mere
The Premier Jumping League (PJL) Launches with a Record-Breaking $300 Million Guaranteed Prize Pot, Defining a New Era for Showjumping30.3.2026 11:00:00 CEST | Press release
The PJL empowers riders to compete as full-time professional athletes while working towards a sustainable economic model for the sport. Backed by McCourt Global and shaped by a leadership team with decades of experience in equestrian competition, sport, and entertainment, the PJL sets a new, sustainable, and globally relevant standard for elite jumping. Sixteen teams will compete across fourteen iconic international venues throughout Europe, North America, and the Middle East when the inaugural season opens in March 2027. The Premier Jumping League (PJL) launches with a record-breaking $300 million guaranteed prize pot, defining a new era for showjumping. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330990938/en/ Photography credits: Daniel Benson for The Premier Jumping League/ Wieden+Kennedy London Backed by McCourt Global and its Executive Chairman, Frank McCourt, the PJL is a groundbreaking global competition that e
Dompé Announces First Patient Enrolled in New Study of Intranasal NGF in Cerebral Palsy30.3.2026 11:00:00 CEST | Press release
Cerebral Palsy (CP) refers to a group of permanent disorders in the development of movement and posture, which causes activity limitations, and is attributed to non-progressive disturbances that occurred in the developing fetal or infant brain.1 Nerve growth factor (NGF) is a naturally-occurring protein that supports damaged nerve cells and improves nervous system signaling, Dompé is investigating whether intranasal NGF has the potential to improve movement and neurodevelopment and address underlying brain damage in people with CP. Dompé’s intranasal NGF platform builds on the Nobel Prize-winning discovery of neurobiologist Professor Rita Levi-Montalcini and biochemist Dr. Stanley Cohen. Dompé, a leading biopharmaceutical company with operations in Italy and in the U.S., announced that the first patient has been enrolled at the Agostino Gemelli IRCCS University Hospital in Rome, Italy, in a Phase 2 investigational study of an intranasal form of Nerve Growth Factor (NGF) (Cenegermin-bkb
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
